PMV PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-29.7M | — |
| FY2018 | — | $-46.1M | — |
| FY2019 | — | $-70.5M | $73.3M |
| FY2020 | — | $359.1M | $361.4M |
| FY2021 | — | $308.6M | $172.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-29.7M | — |
| FY2018 | — | $-46.1M | — |
| FY2019 | — | $-70.5M | $73.3M |
| FY2020 | — | $359.1M | $361.4M |
| FY2021 | — | $308.6M | $172.5M |